Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mongolian Medicine ZhenBao Pills for Limb Function Recovery After Acute Ischemic Stroke
NCT06049498Completed
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Jan 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Zhenbao Jiedu Capsule in ischemic stroke (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Fugl-Meyer Assessment for Upper Extremity at 90 days. Started Jan 2024; status: completed.
02
Drugs
Zhenbao Jiedu Capsule
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06049498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06049498.